Herein, we report two female patients with RA with cavitary pul-monary nodules and aim to obtain more detail data by means of reviewing previously reported cases.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Rheumatoid nodules are the most common pulmonary manifestations of rheumatoid arthritis (RA)and are usually asymptomatic.
📊
Temel Bulgular & Veri:In rare cases, they progress cavitary formation and cause severe clinicalsymptoms because of disease activity, infectious diseases, and other etiologies.
💡
Sonuç & Katkı:Herein, we report two female patients with RA with cavitary pul-monary nodules and aim to obtain more detail data by means of reviewing previously reported cases.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Rheumatoid nodules are the most common pulmonary manifestations of rheumatoid arthritis (RA)and are usually asymptomatic. In rare cases, they progress cavitary formation and cause severe clinicalsymptoms because of disease activity, infectious diseases, and other etiologies. The determinationof clinical and histopathological features may be helpful for differential diagnosis in patients with RAwith cavitary pulmonary nodules. Herein, we report two female patients with RA with cavitary pul-monary nodules and aim to obtain more detail data by means of reviewing previously reported cases.
🔖
Bu Makaleye Atıf Yap
ÜRER, H. N., BES, C., KANITEZ, N. A., ÇETİNKAYA, E., ÖNER, S. Y., ÇELİK, S. (2022). Cavitary pulmonary nodules in rheumatoid arthritis; case reports and review of the literature. European Journal of Rheumatology, Cilt: 5 - Sayı: 1, 65–68. https://ajindex.com/articles/511676
Brown KK. Rheumatoid lung disease. Proc Am Thorac Soc 2007; 15: 443-8. [CrossRef] Gomez Herrero H, ArraizaSarasa M, Rubio Mar- co I, Garciade Eulate Martin-Moro I. Pulmonary rheumatoid nodules: presentation, methods, diagnosis and progression in referenceto 5 cas- es. Reumatol Clin 2012; 8: 212-5. [CrossRef] Ziff M. Rheumatoid nodule. Arthritis Rheum 1990; 33: 761-7. [CrossRef] Cortet B, Flipo RM, Rémy-Jardin M, Coquerelle P, Duquesnoy B, Rêmy J, et al. Use of high res- olution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 815-9. [CrossRef] Pagnoux C, Seror R, BerezneA, Rouabhia S, Goulvestre C, Guillevin L. Remittent non-de- structive polysynovitis in p-ANCA-positive vas- culitis patients with anti-CCP antibodies. Joint Bone Spine 2010; 77: 604-7 [CrossRef] Chinoy H, Mc Kenna F. Wegener’s granulomato- sis in patients with rheumatoid arthritis. Rheu- matology (Oxford) 2002; 41: 588-9. [CrossRef] Bosch X, Llena J, Collado A, Front J, Mirapeix E, Ingelmo M, et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J Rheumatol 1995; 22: 2038-45.
Corcoran JP, Ahmad M, Mukherjee R, Redmond KC. Pleuro-pulmonary complications of rheu- matoid arthritis. Respir Care 2014; 59: 55-9. [CrossRef] Kim SH, Yoo WH. Recurrent pneumothorax as- sociated with pulmonary nodulesafter leflun- omide therapy in rheumatoid arthritis: a case reportand review of the literature. Rheumatol Int 2011; 31: 919-22. [CrossRef] Rozin A, Yigla M, Guralnik L, Keidar Z, Vlodavsky E, Rozenbaum M, et al. Rheumatoid lung nod- ulosis and osteopathy associated with lefluno- mide therapy. Clin Rheumatol 2006; 25: 384-8. [CrossRef] Be M, Cha HJ, Park C, Park Y, Jung H, Lee Y, et al. Multiple pulmonary cavitary nodules with pyoderma gangrenosum in patient with rheu- matoid arthritis. Ann Transl Med 2016; 4: 39. Kobayashi T, Satoh K, Ohkawa M, Satoh A. Multi- ple rheumatoid nodules with rapid thin-walled cavity formation producing pneumothorax. J Thorac Imaging 2005; 20: 47-9. [CrossRef] Yoshikawa GT, Dias GA, Fujihara S, Silva LF, Cruz Lde B, Fuzii HT, et al. Formation of multiple pul- monary nodules during treatment with lefluno- mide. J Bras Pneumol 2015; 41: 281-4. [CrossRef] Gotsman I, Goral A, Nusair S. Secondary spon- taneous pneumothorax in a patient with pul- monary rheumatoid nodules during treatment with methotrexate. Rheumatology (Oxford) 2001; 40: 350-1. [CrossRef] Ayse B, Veli Ç. Pu